Application 211564
- Type
- ANDA
- Sponsor
- GLENMARK GENERICS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DAPAGLIFLOZIN | DAPAGLIFLOZIN | UNKNOWN | UNKNOWN | No | No |
| 002 | DAPAGLIFLOZIN | DAPAGLIFLOZIN | TABLET;ORAL | 10MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DAPAGLIFLOZIN | DAPAGLIFLOZIN | Bryant Ranch Prepack | 05c3cf00-8c2a-4227-958a-fa5db34512b0 | 2026-09-08 | Warnings, Adverse reactions | DAPAGLIFLOZIN DAPAGLIFLOZIN |
| DAPAGLIFLOZIN | DAPAGLIFLOZIN | Biocon Pharma Inc. | 828f1004-3647-9a13-8008-c4b3759ecfd0 | 2026-08-21 | Warnings, Adverse reactions | DAPAGLIFLOZIN DAPAGLIFLOZIN |
| Dapagliflozin | DAPAGLIFLOZIN | Sandoz Inc | 8296f538-4c23-4d6c-be53-8005b83c24b7 | 2026-07-30 | Warnings, Adverse reactions | Dapagliflozin DAPAGLIFLOZIN |
| Dapagliflozin | DAPAGLIFLOZIN | Aurobindo Pharma Limited | f56593f7-588e-489d-9fad-b459e90dab18 | 2026-07-17 | Warnings, Adverse reactions | Dapagliflozin DAPAGLIFLOZIN |
| FARXIGA | DAPAGLIFLOZIN | A-S Medication Solutions | 01f90c94-71cb-4a1f-81ff-8004b850529b | 2026-07-10 | Warnings, Adverse reactions | DAPAGLIFLOZIN |
| dapagliflozin | DAPAGLIFLOZIN | Macleods Pharmaceuticals Limited | 91373924-66dc-4277-aaf2-8536e81a0e4d | 2026-07-09 | Warnings, Adverse reactions | dapagliflozin DAPAGLIFLOZIN |
| Dapagliflozin | DAPAGLIFLOZIN | Ajanta Pharma USA Inc. | f615d81e-d1e8-4561-a4d9-286c615d3bd2 | 2026-07-06 | Warnings, Adverse reactions | Dapagliflozin DAPAGLIFLOZIN |
| DAPAGLIFLOZIN | DAPAGLIFLOZIN | Florida Pharmaceutical Products, LLC | 20a83ea2-6ad8-4bbb-b516-73c0a9e37399 | 2026-07-02 | Warnings, Adverse reactions | DAPAGLIFLOZIN DAPAGLIFLOZIN |
| Dapagliflozin | DAPAGLIFLOZIN | ANI Pharmaceuticals, Inc. | 6425d240-5dd9-4a2c-9348-f8a859702850 | 2026-06-29 | Warnings, Adverse reactions | Dapagliflozin DAPAGLIFLOZIN |
| Dapagliflozin | DAPAGLIFLOZIN | Lupin Pharmaceuticals, Inc. | 08baca21-e39e-4e61-961f-d89432fe8007 | 2026-06-26 | Warnings, Adverse reactions | Dapagliflozin DAPAGLIFLOZIN |
| Dapagliflozin | DAPAGLIFLOZIN | Ascend Laboratories, LLC | b6b8a10c-64c3-4856-8961-d72d68784f5d | 2026-06-25 | Warnings, Adverse reactions | Dapagliflozin DAPAGLIFLOZIN |
| DAPAGLIFLOZIN | DAPAGLIFLOZIN | Alembic Pharmaceuticals Inc. | 840e2146-2383-489b-bcc4-fecfe986685a | 2026-06-23 | Warnings, Adverse reactions | DAPAGLIFLOZIN DAPAGLIFLOZIN |
| Dapagliflozin | DAPAGLIFLOZIN | Zydus Pharmaceuticals USA Inc. | 17586ec6-0104-4b08-ad87-12a837568d6c | 2026-06-22 | Warnings, Adverse reactions | Dapagliflozin DAPAGLIFLOZIN |
| DAPAGLIFLOZIN | DAPAGLIFLOZIN | Cipla USA Inc. | a2f86c0a-ce78-4d06-b5d8-ed457c8e3614 | 2026-06-22 | Warnings, Adverse reactions | DAPAGLIFLOZIN DAPAGLIFLOZIN |
| DAPAGLIFLOZIN | DAPAGLIFLOZIN | Teva Pharmaceuticals, Inc. | 0406a1c0-56b1-4ea1-95ae-00357ac1ba7e | 2026-06-21 | Warnings, Adverse reactions | DAPAGLIFLOZIN DAPAGLIFLOZIN |
| Dapagliflozin | DAPAGLIFLOZIN | Novadoz Pharmaceuticals LLC | 107b4d25-4764-42b7-80e3-9aaff20865ed | 2026-06-17 | Warnings, Adverse reactions | Dapagliflozin DAPAGLIFLOZIN |
| DAPAGLIFLOZIN | DAPAGLIFLOZIN | Prasco Laboratories | 3aba33aa-f8c6-4b10-85c8-dfa14578d07c | 2026-06-03 | Warnings, Adverse reactions | DAPAGLIFLOZIN DAPAGLIFLOZIN |
| FARXIGA | DAPAGLIFLOZIN | AstraZeneca Pharmaceuticals LP | 72ad22ae-efe6-4cd6-a302-98aaee423d69 | 2026-06-03 | Warnings, Adverse reactions | DAPAGLIFLOZIN |
| Dapagliflozin | DAPAGLIFLOZIN | AvKARE | 52a778e7-6044-2049-e063-6294a90aa0b7 | 2026-05-27 | Warnings, Adverse reactions | Dapagliflozin DAPAGLIFLOZIN |
| Dapagliflozin | DAPAGLIFLOZIN | A-S Medication Solutions | addc6ead-f9e3-4b40-aed1-bc008a5c9b0f | 2026-05-18 | Warnings, Adverse reactions | Dapagliflozin DAPAGLIFLOZIN |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 63097 | ORIG | 2020-05-19 |